Company Filing History:
Years Active: 2022-2025
Title: Innovations by Inventor Tao Zuo
Introduction
Tao Zuo is a notable inventor based in Qingzhou, China. He has made significant contributions to the field of fecal microbiota transplantation (FMT) through his innovative research and inventions. With a total of 2 patents, his work focuses on enhancing the efficacy of FMT treatments.
Latest Patents
Tao Zuo's latest patents include two groundbreaking inventions. The first patent, titled "Fecal fungome and therapeutic efficacy of fecal microbiota transplantation," reveals that the altered abundance of fungal species in the gut and feces of both FMT donors and recipients can influence the treatment's outcome. This invention provides novel methods for identifying suitable donors or recipients for FMT, assessing the likelihood of treatment success, and enhancing treatment efficacy. Additionally, it includes kits and compositions designed for FMT with improved effectiveness. The second patent, "Fecal virome and therapeutic efficacy of fecal microbiota transplantation," highlights the importance of viral species' abundance and diversity in fecal matter from donors. This invention also offers methods for identifying suitable donors, assessing treatment success likelihood, and enhancing FMT efficacy, along with corresponding kits and compositions.
Career Highlights
Tao Zuo is affiliated with The Chinese University of Hong Kong, where he conducts his research and develops his innovative ideas. His work has garnered attention in the scientific community, contributing to advancements in microbiota research and therapeutic applications.
Collaborations
Tao Zuo collaborates with esteemed colleagues, including Siew Chien Ng and Ka Leung Francis Chan. Their combined expertise enhances the research and development of innovative solutions in the field of fecal microbiota transplantation.
Conclusion
Tao Zuo's contributions to the field of fecal microbiota transplantation through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly improve treatment outcomes for patients undergoing FMT.